Hjem › Prostatakreft › Virginia › Arlington
Kliniske studier for Prostatakreft i Arlington, VA
17 studier for Prostatakreft søker deltakere på steder i og rundt Arlington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
- Inova Fair Oaks Hospital, Fairfax · 11 mi unna
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekruttererFase 3
- Inova Schar Cancer Institute ( Site 0017), Fairfax · 11 mi unna
- Virginia Cancer Specialists (VCS) ( Site 8004), Fairfax · 11 mi unna
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RekruttererFase 2/3
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RekruttererFase 1
- Investigational Site number: 404, Fairfax · 11 mi unna
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RekruttererFase 1
- NEXT Oncology, Fairfax · 11 mi unna
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
RekruttererFase 2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
RekruttererFase 1
- Virginia Cancer Specialists PC, Fairfax · 11 mi unna
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
RekruttererFase 1/2
- NEXT Oncology - Virginia, Fairfax · 11 mi unna
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RekruttererFase 1
- Virginia Oncology Associates, Fairfax · 11 mi unna
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Rekrutterer
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
RekruttererFase 1/2
- NEXT Oncology, Fairfax · 11 mi unna
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi unna
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RekruttererFase 1/2
- NEXT, Virginia, Fairfax · 11 mi unna
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
Rekrutterer
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site 102, Fairfax · 11 mi unna
- Research Site 112, Fairfax · 11 mi unna
Prostatakreft-studier i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN43 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Arlington
- Ikke-småcellet lungekreft104 studier
- Metastatisk kreft53 studier
- Kolorektal kreft52 studier
- Kreft (alle typer)48 studier
- Brystkreft47 studier
- Eggstokkreft46 studier
- Lungekreft41 studier
- Endometriekreft39 studier
- Pankreaskreft33 studier
- Plateepitelcancer i hode og hals26 studier
- Småcellet lungekreft23 studier
- Mavekreft20 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.